HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Atomo Diagnostics Wins Approval For Australia’s First HIV Self-Test, And Secures WHO Endorsement

Executive Summary

Atomo Diagnostics’ HIV Self Test has got the green light as Australia’s first HIV self-test and won approval from the World Health Organization’s Expert Review Panel for Diagnostics. The Australia-based company has also been granted the European Union (EU) CE Mark for marketing the device within Europe. 

You may also be interested in...



HIV self-test hits German shelves

Teva’s Ratiopharm is offering German consumers for the first time an OTC at-home HIV self-test following the approval by the Bundestag last month of an amendment to the German Medical Device Levy, the MPA, making these products available in pharmacies, drugstores and supermarkets.

French consumers seek easy access to self tests

The French general public has voiced its support for increased availability of various diagnostic self tests outside of traditional pharmacies.

ABDA wants test restriction

German pharmacists’ association, ABDA, has urged the country’s Ministry of Health, the BMG, to reconsider its proposal to make at-home HIV tests available in drugstores and supermarkets, calling for a pharmacy- only restriction to be added to ensure patients still have access to expert advice.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS139950

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel